Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Poster Session

Thumbnail for Continuous Cumulative Exposure to Covalent BTK Inhibitors and the Nonlinear Acceleration of Incident Atrial Fibrillation in Chronic Lymphocytic Leukemia: A Primary Restricted Cubic Spline Meta-Analysis

CLL - 1494

Continuous Cumulative Exposure to Covalent BTK Inhibitors and the Nonlinear Acceleration of Incident Atrial Fibrillation in Chronic Lymphocytic Leukemia: A Primary Restricted Cubic Spline Meta-Analysis

Raj Nandan Chennuri

Poster Presenter: Raj Nandan Chennuri

Thumbnail for BTK Inhibitors Versus Venetoclax and Obinutuzumab in Anticoagulated Chronic Lymphocytic Leukemia Patients: A Propensity-Matched Analysis of Bleeding Outcomes

CLL - 1503

BTK Inhibitors Versus Venetoclax and Obinutuzumab in Anticoagulated Chronic Lymphocytic Leukemia Patients: A Propensity-Matched Analysis of Bleeding Outcomes

Vedant Shah

Poster Presenter: Vedant Shah

Thumbnail for Real-World Overall Survival, Richter's Transformation, and Secondary Primary Malignancy Rates in CLL being treated with Fixed-Duration Venetoclax-Based Therapy vs. Indefinite BTK Inhibitor Monotherapy: A TriNetX Propensity-Matched Analysis

CLL - 1511

Real-World Overall Survival, Richter's Transformation, and Secondary Primary Malignancy Rates in CLL being treated with Fixed-Duration Venetoclax-Based Therapy vs. Indefinite BTK Inhibitor Monotherapy: A TriNetX Propensity-Matched Analysis

Avi Harisingani

Poster Presenter: Avi Harisingani

$Thumbnail for Predicting Tolerance and Responses to BTKi in CLL Patients with Treatment-Naοve or Relapsed/Refractory Disease Using Pharmacogenomics$

CLL - 1544

Predicting Tolerance and Responses to BTKi in CLL Patients with Treatment-Naοve or Relapsed/Refractory Disease Using Pharmacogenomics

Fahmin Basher

Poster Presenter: Fahmin Basher

Thumbnail for Survival Trends and Prevalence Disparities in Large Granular Lymphocytic Leukemia: A Multivariate Population Based Retrospective Study.

CLL - 1546

Survival Trends and Prevalence Disparities in Large Granular Lymphocytic Leukemia: A Multivariate Population Based Retrospective Study.

Hassan Ali

Poster Presenter: Hassan Ali

Thumbnail for Temporal Trends in Cardiovascular Toxicity with Second-Generation BTK Inhibitors: Acalabrutinib versus Zanubrutinib

CLL - 1549

Temporal Trends in Cardiovascular Toxicity with Second-Generation BTK Inhibitors: Acalabrutinib versus Zanubrutinib

Ansy Patel

Poster Presenter: Ansy Patel

Thumbnail for Cardiovascular Toxicity of Ibrutinib Versus Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity Score-Matched TriNetX Database Analysis

CLL - 1557

Cardiovascular Toxicity of Ibrutinib Versus Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity Score-Matched TriNetX Database Analysis

Wei Ju Lin

Poster Presenter: Wei Ju Lin

Thumbnail for Outcomes of Venetoclax Retreatment After Prior Frontline Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis

CLL - 1558

Outcomes of Venetoclax Retreatment After Prior Frontline Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis

Mutasim Idriss

Poster Presenter: Mutasim Idriss

Thumbnail for Concurrent Hemophagocytosis and Hodgkin Lymphoma-Type Richter Transformation in CLL/SLL: An Incidental Finding With Therapeutic Implications

CLL - 1564

Concurrent Hemophagocytosis and Hodgkin Lymphoma-Type Richter Transformation in CLL/SLL: An Incidental Finding With Therapeutic Implications

Jillianne Unas

Poster Presenter: Jillianne Unas